Stearic Acid

Stearic Acid

SCHEMBL526578

CCCCCCCCCCCCCCCCCC(=O)O.CCN(CC)CCN

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Stearic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
FABP4 P15090 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
KMT2A Q03164 2/20 0.61
ALOX15 P16050 2/20 0.61
HSD17B10 Q99714 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
PDE4A P27815 1/20 0.61
PDE3A Q14432 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Palmitic Acid SCHEMBL19640923 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL19640928 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL19640925 1.00 GPR84 (0.61) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL7783095 0.98 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Adipic Acid SCHEMBL27765050 0.93 CYP2D6 (0.54) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL722130 0.91 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Behenic Acid SCHEMBL20835366 0.91 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Myristic Acid SCHEMBL22204639 0.91 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Palmitic Acid SCHEMBL20835361 0.91 GPR84 (0.59) GPR84PPARGPPARDPPARAHDAC11
Stearic Acid SCHEMBL4139803 0.91 GPR84 (0.50) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 347 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3659580-B1 CLEANSER COMPOSITION KAO CORP (JP) 2025-11-05 EP claimed
US-11628130-B2 Cleanser composition KAO CORPORATION (JP) 2023-04-18 US claimed
CN-110958872-B Cleaning agent composition 花王株式会社 2023-03-14 CN claimed
CN-109549860-B Preparation method of positively charged liposome and charged liposome J网络公司 2022-06-07 CN claimed
US-20210145720-A1 CLEANSER COMPOSITION KAO CORPORATION (JP) 2021-05-20 US claimed
US-11000477-B2 Preparing method for positively-electrified charged niosome, and charged niosome J-NETWORK, INC. (US) 2021-05-11 US claimed
EP-3659580-A1 CLEANSER COMPOSITION Kao Corporation (JP) 2020-06-03 EP claimed
CN-110958872-A Cleaning agent composition 花王株式会社 2020-04-03 CN claimed
US-20190091153-A1 PREPARING METHOD FOR POSITIVELY-ELECTRIFIED CHARGED NIOSOME, AND CHARGED NIOSOME J-NETWORK, INC. (US) 2019-03-28 US claimed
EP-3459525-A1 PREPARING METHOD FOR POSITIVELY-ELECTRIFIED CHARGED NIOSOME, AND CHARGED NIOSOME J-Network, Inc. (US) 2019-03-27 EP claimed
JP-63280403-A None JP disclosed
CN-122005622-A Composition for improving, preventing or treating vaginitis or vulvitis comprising lactobacillus salivarius HHuMin-U 比菲德股份有限公司 2026-05-12 CN disclosed
US-12582590-B2 Transparent liquid composition and cosmetic containing said composition SEIWA KASEI COMPANY, LIMITED (JP) 2026-03-24 US disclosed
EP-3368592-B1 COSMETIC COMPOSITION, COSMETIC, AND EXTERNAL PREPARATION FOR SKIN DOW TORAY CO LTD (JP) 2025-12-03 EP disclosed
EP-3659580-B1 CLEANSER COMPOSITION KAO CORP (JP) 2025-11-05 EP disclosed
US-5603861-A NONAQUEOUS; DIELECTRIC TONEN CORPORATION (JP) 1997-02-18 US disclosed
EP-0743847-A1 HAIR COSMETIC COMPOSITION Kao Corporation (JP) 1996-11-27 EP disclosed
EP-0671460-A1 ELECTROVISCOUS FLUID Tonen Corporation (JP) 1995-09-13 EP disclosed
WO-1995020375-A1 HAIR COSMETIC COMPOSITION KAO CORPORATION (JP) 1995-08-03 WO disclosed
JP-S63280403-A CONDUCTIVE MAGNETIC FLUID COMPOSITING AND MANUFACTURE THEREOF NIPPON SEIKO KK 1988-11-17 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210145720-A1 CLEANSER COMPOSITION ADH1C, WASHC4, AP2S1 GPR84 694/4885PPARG 1669/4885PPARD 2124/4885
US-11628130-B2 Cleanser composition ADH1C, SMURF1, DEGS1 GPR84 745/4885PPARG 1454/4885PPARD 1600/4885
US-12582590-B2 Transparent liquid composition and cosmetic containing said composition GK, CUTA, GHDC GPR84 1497/4885PPARG 117/4885PPARD 1161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.